These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22461648)

  • 1. KRAS mutational status of endoscopic biopsies matches resection specimens.
    Yang QH; Schmidt J; Soucy G; Odze R; Dejesa-Jamanila L; Arnold K; Kuslich C; Lash R
    J Clin Pathol; 2012 Jul; 65(7):604-7. PubMed ID: 22461648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma.
    Pang NK; Nga ME; Chin SY; Ismail TM; Lim GL; Soong R; Salto-Tellez M
    Cytopathology; 2011 Dec; 22(6):358-64. PubMed ID: 21029218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between KRAS mutations and clinicopathologic features in colorectal carcinomas].
    Gao J; Zhang J; Lu T; Li XY; Jia N; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):595-8. PubMed ID: 23157826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of the infrequent mosaicism of KRAS mutational status in metastatic colorectal adenocarcinomas.
    Bossard C; Küry S; Jamet P; Senellart H; Airaud F; Ramée JF; Bézieau S; Matysiak-Budnik T; Laboisse CL; Mosnier JF
    J Clin Pathol; 2012 May; 65(5):466-9. PubMed ID: 22259183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations.
    Kimura K; Nagasaka T; Hoshizima N; Sasamoto H; Notohara K; Takeda M; Kominami K; Iishii T; Tanaka N; Matsubara N
    J Int Med Res; 2007; 35(4):450-7. PubMed ID: 17697521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.
    Krol LC; 't Hart NA; Methorst N; Knol AJ; Prinsen C; Boers JE
    Eur J Cancer; 2012 May; 48(7):1108-15. PubMed ID: 22446020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of KRAS gene mutation and its clinical significance in colorectal adenocarcinoma].
    Xu C; Liu YL; Huang J; He DM; Hou YY; Ji Y; Hou J; Lu SH; Xu JF; Hu Q; Shi Y; Zhao LJ; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):667-70. PubMed ID: 23302307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor and Kras gene expression: reliability of mutational analysis on cytological samples.
    Bozzetti C; Negri FV; Azzoni C; Naldi N; Nizzoli R; Bortesi B; Zobbi V; Bottarelli L; Tiseo M; Silini EM; Ardizzoni A
    Diagn Cytopathol; 2013 Jul; 41(7):595-8. PubMed ID: 22833420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS mutation analysis on cytological specimens of metastatic colo-rectal cancer.
    Troncone G; Malapelle U; Cozzolino I; Palombini L
    Diagn Cytopathol; 2010 Dec; 38(12):869-73. PubMed ID: 20049979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene.
    Sameer AS; Chowdri NA; Syeed N; Banday MZ; Shah ZA; Siddiqi MA
    BMC Cancer; 2010 Jun; 10():300. PubMed ID: 20565773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer.
    Fadhil W; Ibrahem S; Seth R; AbuAli G; Ragunath K; Kaye P; Ilyas M
    Histopathology; 2012 Dec; 61(6):1117-24. PubMed ID: 22882224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.
    Italiano A; Hostein I; Soubeyran I; Fabas T; Benchimol D; Evrard S; Gugenheim J; Becouarn Y; Brunet R; Fonck M; François E; Saint-Paul MC; Pedeutour F
    Ann Surg Oncol; 2010 May; 17(5):1429-34. PubMed ID: 20049644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of polypoid colorectal adenocarcinoma with pre-existing adenomatous polyps and KRAS mutation.
    Chen H; Lefferts JA; Schwab MC; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2011 May; 204(5):245-51. PubMed ID: 21665177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.
    Carotenuto P; Roma C; Rachiglio AM; Tatangelo F; Pinto C; Ciardiello F; Nappi O; Iaffaioli RV; Botti G; Normanno N
    Pharmacogenomics; 2010 Aug; 11(8):1169-79. PubMed ID: 20712532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
    Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
    Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The frequency and spectrum of KRAS mutations in metastatic colorectal cancer].
    Mazurenko NN; Gagarin IM; Tsyganova IV; Mochal'nikova VV; Breder VV
    Vopr Onkol; 2013; 59(6):751-5. PubMed ID: 24624786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BRAF gene mutation in wild-type KRAS patients with colorectal cancers].
    Roa I; Game A; Bizama C; Schalper K
    Rev Med Chil; 2014 Jan; 142(1):55-60. PubMed ID: 24861115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients.
    Rako I; Jakic-Razumovic J; Katalinic D; Sertic J; Plestina S
    Neoplasma; 2012; 59(4):376-83. PubMed ID: 22489692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.